Zisman A,Pantuck AJ,Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002; 20: 4559–4566.

Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012; 23(suppl 7):vii65–vii71.

Patard J, et al. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study. JCO Aug 15, 2004:3316-3322

Dr. Amnon Zisman

UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC)

disease

fuhrman

ecog

<p>Provides 5-year disease-free prognosis for localized and metastatic RCC.</p>

UISS for RCC

UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC) provides 5-year disease-free prognosis for localized and metastatic RCC.

Fuhrman Nuclear Grade

IMDC Model for mRCC

Mekhail Extension

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function